Add BrightSurf on Google Email

Tiny cell messengers in obese individuals accelerate Alzheimer’s-linked plaque buildup in the brain

A new study found that adipose-derived extracellular vesicles, tiny cell messengers in obese individuals, accelerate the buildup of amyloid-β plaques in the brain, a hallmark of Alzheimer's disease. Researchers hope targeting these tiny cell messengers could reduce the risk of Alzheimer's disease in people with obesity.

SourceHouston Methodist·JournalAlzheimer s & Dementia·TypeExperimental study·DateOct 2, 2025

Family-based intervention programs are insufficient to prevent childhood obesity, major study finds

A landmark study by the University of Sydney found that family-based early obesity prevention programs did not improve BMI in young children. The researchers analyzed data from 17 international studies and concluded that environmental and structural drivers are key to addressing childhood obesity. Governments, health officials, and loc...

SourceUniversity of Sydney·JournalThe Lancet·TypeMeta-analysis·DateSep 10, 2025

BMI a poor predictor of future health

A new study published in the Annals of Family Medicine has found that body mass index (BMI) is not a reliable predictor of future health risks and heart disease mortality. In contrast, bioelectrical impedance analysis, which measures body fat directly, was shown to be significantly more accurate, with individuals having high body fat l...

SourceUniversity of Florida·JournalThe Annals of Family Medicine·DateJun 25, 2025

Is your heart aging too fast?

A new MRI technique measures a person's 'functional age' of their heart, revealing how unhealthy lifestyles add years to their heart's aging process. This method has the potential to transform heart disease diagnosis and offer a lifeline to millions by catching problems early.

SourceUniversity of East Anglia·JournalOpen Heart·TypeObservational study·DateMay 1, 2025

Study estimates proportion of adolescents living with overweight and obesity in England has increased by 50% between 2008 and 2023

Research found a significant increase in the prevalence of overweight and obesity among English adolescents, from 22% to 33% between 2008-2010 and 2021-2023. Adolescents living with these conditions are at higher risk for developing comorbidities, including mental health issues, physical problems, and cardiometabolic diseases.

Tirzepatide can produce clinically meaningful weight loss for at least 3 years in adults with overweight or obesity who don’t have diabetes

A new study found that tirzepatide can produce sustained weight loss of up to 31% in adults with overweight or obesity without diabetes, regardless of age or BMI. The study also identified patterns of weight loss trajectories and found that females and those without obesity-related complications may be more responsive to the medication.

Most older adults say Medicare and other insurance should cover obesity drugs, and many show interest in using them

A large majority of older Americans believe health insurance – including Medicare – should cover anti-obesity medications. Nearly 37% of respondents met the criteria for overweight and 36% for obesity. Medicare currently covers a drug used for weight management but only in people with diabetes or a history of heart attack or stroke.

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeSurvey·DateMar 26, 2025

Do lifetime body weight patterns affect kidney cancer risk?

New research suggests that maintaining a healthy weight throughout life and losing weight later in life may reduce the risk of kidney cancer. Higher BMI at various ages across adulthood was associated with increased risks of developing different types of kidney cancer, including renal cell carcinoma, papillary RCC, and chromophobe RCC.

SourceWiley·JournalCancer·DateMar 24, 2025

Study uncovers link between childhood overweight and obesity and chronic obstructive pulmonary disease in adulthood

Research suggests that having an overweight or obesity trajectory during childhood is associated with a higher risk of chronic obstructive pulmonary disease (COPD) in adulthood. The study found that women with above-average childhood BMI trajectories had a 26% higher risk, while those with an obesity BMI trajectory had a 65% higher risk.

Weight loss increases risk of death for obese adults

A recent study published in Heart journal found that extreme weight fluctuations significantly increase the risk of death among obese individuals with cardiovascular disease. Both weight loss and gain above 10kg raise mortality risk, highlighting the importance of maintaining a stable weight even within the obese range.

SourceAnglia Ruskin University·JournalHeart·TypeData/statistical analysis·DateMar 12, 2025

THE LANCET: More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050

A major new analysis predicts that over half the world's adult population (3.8 billion) and a third of all children and adolescents (746 million) will be living with overweight or obesity by 2050. The study forecasts a substantial rise in obesity among young people globally, with an additional 186 million cases predicted by 2050.

SourceThe Lancet·JournalThe Lancet·TypeComputational simulation/modeling·DateMar 3, 2025

Reduced prediabetes in people who ate broccoli compound

A study by University of Gothenburg researchers found that consuming sulforaphane from broccoli sprouts improved blood sugar levels in people with prediabetes. The compound had a significant effect on fasting blood sugar levels, particularly in those with certain pathophysiological and microbiome characteristics.

SourceUniversity of Gothenburg·JournalNature Microbiology·TypeRandomized controlled/clinical trial·DateFeb 13, 2025